Crunchbase News

DECEMBER 3, 2024

Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.

Biotech 99

Biotech Compliance Technical Review Marketing 99

TechCrunch

MARCH 24, 2021

Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. LiliumX is taking the algorithmic approach to generating potential antibody stuctures that could be effective, as many AI-informed biotech companies have before it. Startups take on big pharma.

Biotech 248

Biotech Tools Technical Review Software Review 248

Crunchbase News

DECEMBER 9, 2024

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.

Biotech 122

Biotech Film Performance Marketing 122

TechCrunch

OCTOBER 28, 2022

In the world of biotech, for example, it’s extremely capital intensive to develop multiple products that are all going through clinical trials simultaneously. A better approach would be to focus on a lead program — a single product that they can take through various stages of development, ultimately leading to FDA approval.

Biotech 242

Biotech Sustainability Programming Healthcare 242

TechCrunch

FEBRUARY 28, 2022

Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.

Biotech 226

Biotech 3D Chemicals Industry 226

N2Growth Blog

OCTOBER 23, 2023

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

Crunchbase News

MARCH 4, 2025

Lambda is also a provider of the latest GPUs by Nvidia , which are highly sought after by AI developers. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025. Harvey develops AI tools that help legal pros with research, document review and contract analysis.

Artificial Intelligence 117

Artificial Intelligence Artificial Inteligence Biotech Lambda 117

TechCrunch

MARCH 21, 2023

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?

Biotech 203

Biotech Development Team Review Technical Review Innovation 203

TechCrunch

DECEMBER 16, 2022

6 investors discuss why AI is more than just a buzzword in biotech. In her latest investor survey, Anna Heim spoke to six biotech investors about where AI creates value, short-term market shifts, and how they’d like to be approached by founders: Robert Mittendorff, M.D, general partner and head of healthcare, B Capital.

Case Study 215

Case Study Biotech Survey Study 215

TechCrunch

APRIL 8, 2022

6 questions investors should ask when evaluating psychedelic biotech companies. With plans to raise a $25 million fund and more than $15 million already invested, PsyMed Ventures focuses on early-stage startups developing psychedelic therapeutics. 6 questions investors should ask when evaluating psychedelic biotech companies. .

Biotech 222

Biotech Windows Transportation Travel 222

CIO

MARCH 4, 2025

Product and service innovation: Software companies now sell AI-driven analytics as products, automakers offer AI features (like driver assist or predictive maintenance) as differentiators and healthcare firms use AI to develop new diagnostics and personalized medicine. Crucially, the time and cost to implement AI have fallen.

Technology 177

Technology Biotech Artificial Inteligence Artificial Intelligence 177

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. However, such therapies are typically costly to develop with no guarantee that they’ll work.

Biotech 258

Biotech Development Pharmaceuticals Machine Learning 258

Crunchbase News

MAY 24, 2024

This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.

Biotech 136

Biotech Healthcare Generative AI Analysis 136

Crunchbase News

FEBRUARY 19, 2025

billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. Alto Neuroscience , developer of a machine learning-driven precision treatment platform for psychiatric care, has also underperformed.

Healthcare 113

Healthcare Artificial Inteligence Biotech Artificial Intelligence 113

Crunchbase News

NOVEMBER 1, 2024

In August, San Francisco-based Magic , which also develops AI models to write software, raised a $320 million round, and AI-powered coding assistant Codeium closed a $150 million Series C. The company is developing advanced small modular nuclear reactors for clean energy generation. Rowe Price. came from across the Pacific.

Biotech 122

Biotech Energy Artificial Intelligence Artificial Inteligence 122

Crunchbase News

JANUARY 13, 2025

Also last week, Palo Alto, California-based Hippocratic AI , which develops a safety-focused large language model for healthcare, safety and accuracy, raised a $141 million Series B valuing the company at $1.6 Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman

Artificial Inteligence 119

Artificial Inteligence Healthcare Biotech Artificial Intelligence 119

TechCrunch

NOVEMBER 27, 2023

Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. Many AI companies in biotech train models […] © 2023 TechCrunch.

Artificial Inteligence 280

Artificial Inteligence Biotech Programming Training 280

Ooda Loop

FEBRUARY 28, 2025

Theres a new kid on the block when it comes to drug companies developing treatments for obesity, and this one has a clear advantage over rivals. a New York-based biotech that went public on Jan. Metsera Inc.,

Biotech 59

Biotech Development Company 59

Dzone - DevOps

MARCH 20, 2025

Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.

Software Development 52

Software Development Biotech Software Development 52

Crunchbase News

JANUARY 10, 2025

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate?

Biotech 113

Biotech Marketing Hardware Industry 113

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

JULY 26, 2021

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. If everything works as advertised, Glyphic could be the new standard in protein sequencing just as demand skyrockets in the biotech world.

Biotech 249

Biotech Off-The-Shelf Chemicals Hardware 249

Crunchbase News

FEBRUARY 4, 2025

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. tied) Retro Biosciences , $1B, biotech: AI can do a lot startup Retro Biosciences thinks it can even help us live longer. billion to develop data centers in Spain. billion valuation.

Biotech 123

Biotech Artificial Intelligence Artificial Inteligence Technical Review 123

TechCrunch

AUGUST 3, 2021

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. . In 2020, 71 biotech companies went public. On July 30 alone, eight biotech companies were expected to begin trading, including Rani Therapeutics. . In an increasingly hot biotech market, protecting IP is key.

Biotech 245

Biotech Study .Net Systems Review 245

Crunchbase News

SEPTEMBER 20, 2024

Of course, biotech and fintech were in there too. tied) Serán Bioscience , $200M, biotech : The big biotech raise this week went to Serán Bioscience. The company will use the fresh capital to support product development, including the launch of flight and rental car bookings to its platform.

Biotech 115

Biotech Travel Fintech Pharmaceuticals 115

TechCrunch

OCTOBER 7, 2021

Any one of these vastly different organisms may very well have developed on its own a novel chemical pathway that could transform food production, drug manufacturing or agriculture. And Hexagon Bio also recently raised on a similar proposition of locating naturally occurring molecules for use in drug development.

Biotech 228

Biotech CTO Coach Fractional CTO Chemicals 228

Crunchbase News

MARCH 28, 2025

Fleetio , $450M, fleet management: Fleet optimization software platform developer Fleetio locked up a $450 million round to finance the acquisition of maintenance authorization platform Auto Integrate. Island , $250M, cybersecurity: Dallas-based enterprise browser developer Island raised a $250 million Series E at a $4.8

Biotech 100

Biotech Artificial Intelligence Artificial Inteligence Transportation 100

Crunchbase News

NOVEMBER 22, 2024

While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns. This includes a $405 million Series F for battery technology company Form Energy and a $400 million Series A for obesity drug developer Kailera Therapeutics. billion Series C in May.

Technical Review 133

Technical Review Artificial Inteligence Biotech Energy 133

TechCrunch

JUNE 6, 2022

Zhavoronkov explained to TechCrunch that the last round “was very substantial and was intended to allow us to fund clinical development” and the company is “trying to be very conservative and careful with the money.” This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

TechCrunch

SEPTEMBER 21, 2021

ahin, his wife and co-founder Özlem Türeci, and the rest of the seven-person founding team began their research. “At that time, mRNA was not potent enough,” ?

Weak Development Team 239

Weak Development Team Biotech Research Technology 239

TechCrunch

OCTOBER 28, 2022

Play-to-earn games (P2E) are particularly susceptible to this problem, which is why “building a game that succeeds in the long term means developing monetization strategies that can weather market ebbs and flows,” says Corey Wilton, co-founder and CEO of Mirai Labs, the gaming studio behind Pegaxy. Development process. Budding Biotech.

Technical Review 228

Technical Review Software Review Development Team Review TDD 228

Crunchbase News

MARCH 21, 2025

Latigo Biotherapeutics , $150M, biotech: Many patients shy away from taking opioids while many doctors are reluctant to prescribe the painkillers. Thousand Oaks, California-based Latigo Biotherapeutics is developing a completely different option for pain relief and raised a $150 million Series B led by funds managed by Blue Owl for it.

Biotech 67

Biotech Software Review Technical Review Analytics 67

TechCrunch

OCTOBER 3, 2022

The software company was developed at Colossal Biosciences — known for its goal to bring extinct critters like the wooly mammoth back to life — and is now striking out on its own. As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform.

Biotech 240

Biotech Software Artificial Inteligence Machine Learning 240

TechCrunch

FEBRUARY 11, 2021

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. ” Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies. ’,” said Solomon.

Artificial Inteligence 305

Artificial Inteligence Machine Learning Biotech Chemicals 305

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4

Research 261

Research Biotech Nonprofit Comparison 261

TechCrunch

AUGUST 22, 2022

Based in Japan, biotech startup Dioseve ’s ambitious goal is to grow human oocytes, or eggs, from other tissue. Dioseve’s mission might sound like it comes out of science fiction, but it’s based on a scientific technique called induced pluripotent cells stem (iPS) cells, which was first developed in 2006.

Biotech 213

Biotech Journal Research Technology 213

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248